List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 640 studies with search of: "Schering-Plough" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(COMPLETED)
Condition: Hepatitis C, Chronic
Intervention: Drug: Combination of pegylated interferon alfa-2b and ribavirin
2 Completed Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: Sugammadex;   Drug: neostigmine
3 Completed A Patient Handling Study of MF/F MDI With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703)(COMPLETED)
Conditions: Asthma;   COPD
Intervention: Drug: SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
4 Completed To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Engage)(Study 38819AM1)(COMPLETED)(P05787)
Condition: In Vitro Fertilization
Interventions: Drug: corifollitropin alfa;   Drug: follitropin beta
5 Active, not recruiting Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM2)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
6 Recruiting Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients (Study P05550AM2)
Conditions: Movement Disorders;   Dyskinesias;   Neurodegenerative Diseases;   Central Nervous System Diseases;   Brain Diseases
Interventions: Drug: Preladenant;   Drug: Levodopa infusion (IV);   Drug: Carbidopa;   Drug: Placebo matched to preladenant;   Drug: Placebo matched to Levodopa infusion (IV);   Drug: Placebo matched to Carbidopa 25-mg
7 Completed Study to Evaluate the Safety and Dose-Range of SCH 527123 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (Study P04592AM4)(COMPLETED)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Drug 1: SCH 527123;   Drug: Drug 2: Placebo to match SCH 527123;   Drug: Drug 3: SCH 527123;   Drug: Drug 4: Placebo to match SCH 527123;   Drug: Drug 5: SCH 527123;   Drug: Drug 6: Placebo to match SCH 527123;   Drug: Drug 7: SCH 527123;   Drug: Drug 8: SCH 527123;   Drug: Drug 9: SCH 527123;   Drug: Drug 10: Placebo to match SCH 527123
8 Completed A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612AM2)(COMPLETED)
Condition: Psoriasis
Intervention: Biological: Infliximab
9 Recruiting The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633AM1)
Conditions: Coronary Artery Bypass;   Myocardial Infarction;   Ventricular Dysfunction, Left;   Stroke;   Cardiopulmonary Bypass
Interventions: Drug: Acadesine;   Drug: Normal Saline
10 Completed Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia (Study P02579AM)(COMPLETED)
Condition: Hypercholesterolemia
Intervention: Drug: ezetimibe
11 Completed Neutrophilic Asthma Study With SCH 527123 (Study P05365AM2)(COMPLETED)
Condition: Neutrophilic Asthma
Interventions: Drug: SCH 527123;   Drug: Placebo
12 Recruiting Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146AM4)
Conditions: Carcinoma, Non-Small-Cell Lung;   Adenocarcinoma;   Carcinoma, Large Cell;   Carcinoma, Squamous Cell
Intervention: Drug: Temozolomide
13 Completed Trial to Assess the Safety and Effects of SCH 530348 in Japanese Subjects With Acute Coronary Syndrome (P04772)(COMPLETED)
Conditions: Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction
Interventions: Drug: SCH 530348;   Drug: Placebo;   Drug: Aspirin;   Drug: Ticlopidine hydrochloride
14 Completed Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition: Allergies
Interventions: Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)
15 Active, not recruiting Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Subjects With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
Conditions: Primary Hypercholesterolemia;   Mixed Hyperlipidemia
Interventions: Drug: SCH 900271;   Drug: Placebo
16 Completed Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)(COMPLETED)
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Interventions: Drug: ezetimibe;   Drug: placebo
17 Completed This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)
Condition: Seasonal Allergic Rhinitis
Intervention: Drug: mometasone furoate
18 Completed Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)(COMPLETED)
Conditions: Hypercholesterolemia;   Atherosclerosis
Interventions: Drug: Ezetimibe;   Drug: Placebo
19 Completed
Has Results 		A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)(COMPLETED)
Condition: Rheumatoid Arthritis
Intervention: Drug: Infliximab
20 Terminated Study of Response in CHC Patients Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (Study P04823AM3)(TERMINATED)
Conditions: Hepatitis C, Chronic;   Insulin Resistance
Intervention: Drug: Combination of pegylated interferon alfa-2b and ribavirin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services